Subsequent experiments confirmed that MYCN could bind to the MTHFD1 promoter region and transcriptionally activate the expression of MTHFD1 in MYCN-amplified NB, validating the molecular mechanism of MYCN regulating MTHFD1. The gene discussed is MTHFD1; the disease is neuroblastoma.